{"schema_version":"1","generated_at":"2026-10-30T02:23:48.710Z","data_as_of":null,"url":"https://www.findmykol.com/kol/milene-saavedra","json_url":"https://www.findmykol.com/kol/milene-saavedra/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"milene-saavedra","name":"Milene Saavedra","credential":"MD","specialty":"Pulmonary Disease","specialty_raw":"Pulmonary Disease","therapeutic_area":"Respiratory","therapeutic_areas":["Respiratory"],"institution":"National Jewish Health","institution_url":"https://www.findmykol.com/institution/national-jewish-health","city":"Denver","state":"CO","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1932299518","orcid":"0000-0001-5962-2064","openalex":"A5036551975"},"summary":"Milene Saavedra is a Respiratory physician affiliated with National Jewish Health. OpenAlex indexes 69 publications with 1,944 citations (h-index 23); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Respiratory"]},"scholarship":{"works_count":69,"cited_by_count":1944,"h_index":23,"latest_activity_year":2026,"source":"works"},"trials":{"count":1,"shown":2,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT02918409","title":"IV Colistin for Pulmonary Exacerbations: Improving Safety and Efficacy","phase":"PHASE4","status":"COMPLETED","role":"Overall official","sponsor":"National Jewish Health","source_url":"https://clinicaltrials.gov/study/NCT02918409","trial_url":"https://www.findmykol.com/trial/NCT02918409"},{"nct":"NCT01626157","title":"A Novel Assay to Quantify Treatment Response in Cystic Fibrosis (CF)","status":"COMPLETED","role":"Overall official","sponsor":"Milene Saavedra","source_url":"https://clinicaltrials.gov/study/NCT01626157","trial_url":"https://www.findmykol.com/trial/NCT01626157"}],"source":"trials"},"payments":{"company_count":9,"program_years":{"first":2021,"last":null},"rows_total":13,"shown":3,"withheld":10,"rows":[{"payer":"ABBVIE INC.","program_year":2025,"amount_usd":78.16,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1932299518"},{"payer":"Aimmune Therapeutics, Inc.","program_year":2025,"amount_usd":15.39,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1932299518"},{"payer":"VERTEX PHARMACEUTICALS INCORPORATED","program_year":2024,"amount_usd":39.83,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1932299518"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1932299518","source":"payments"},"prescribing":{"data_year":2024,"areas_total":6,"areas_shown":3,"areas":[{"area":"Respiratory","share_pct":48.7,"classes_total":5,"classes":[{"class":"Other respiratory system products","setting":"prescribed","share_pct":29.7,"drugs":[{"name":"Trikafta","share_pct":100}],"max_beneficiaries":32},{"class":"beta2-Adrenergic Agonist","setting":"prescribed","share_pct":6.5,"drugs":[{"name":"Albuterol Sulfate Hfa","share_pct":50.8},{"name":"Ventolin Hfa","share_pct":49.2}],"max_beneficiaries":null}]},{"area":"Metabolism & gastrointestinal","share_pct":32.3,"classes_total":7,"classes":[{"class":"Antidiarrheal microorganisms","setting":"prescribed","share_pct":11.3,"drugs":[{"name":"Zenpep","share_pct":55.8},{"name":"Creon","share_pct":27.4},{"name":"Pertzye","share_pct":16.8}],"max_beneficiaries":null},{"class":"Corticosteroid","setting":"prescribed","share_pct":5.3,"drugs":[{"name":"Prednisone","share_pct":100}],"max_beneficiaries":null}]},{"area":"Anti-infectives","share_pct":8.8,"classes_total":4,"classes":[{"class":"Macrolide Antimicrobial","setting":"prescribed","share_pct":3.6,"drugs":[{"name":"Azithromycin","share_pct":100}],"max_beneficiaries":null},{"class":"Fluoroquinolone Antibacterial","setting":"prescribed","share_pct":2.2,"drugs":[{"name":"Levofloxacin","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":0,"facility_pct":100},"source":"medicare"},"funding":{"award_count":2,"fiscal_years":{"first":2003,"last":2026},"rows_total":6,"shown":3,"withheld":3,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"R03AI199486","title":"Glucose and glutamine transport: novel targets in cystic fibrosis immune responses","fiscal_year":2026,"amount_usd":"164350","organization":"NATIONAL JEWISH HEALTH","source_url":"https://reporter.nih.gov/quickSearch/R03AI199486"},{"project":"K08HL074512","title":"Kruppel like factor in P. aeruginosa airway virulence","fiscal_year":2007,"amount_usd":"131490","organization":"UNIVERSITY OF COLORADO DENVER","source_url":"https://reporter.nih.gov/quickSearch/K08HL074512"},{"project":"K08HL074512","title":"Kruppel like factor in P. aeruginosa airway virulence","fiscal_year":2006,"amount_usd":"131490","organization":"UNIVERSITY OF COLORADO DENVER","source_url":"https://reporter.nih.gov/quickSearch/K08HL074512"}],"source":"grants"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Mental health and adherence in CF: Self-efficacy and perceived barriers as mediators","year":2025,"journal":"Journal of Cystic Fibrosis","source_url":"https://doi.org/10.1016/j.jcf.2025.02.016","status":"verified"},{"title":"Olfaction, Eating Preference, and Quality of Life in Cystic Fibrosis Chronic Rhinosinusitis","year":2025,"journal":"The Laryngoscope","source_url":"https://doi.org/10.1002/lary.32155","status":"verified"},{"title":"The changing face of inflammation following CFTR modulation: identifying new phenotypes of innate immunity","year":2025,"journal":"Thorax","source_url":"https://doi.org/10.1136/thorax-2025-223460","status":"verified"},{"title":"Predictors of Sinonasal Improvement After Highly Effective Modulator Therapy in Adults with Cystic Fibrosis","year":2024,"journal":"The Laryngoscope","source_url":"https://doi.org/10.1002/lary.31438","status":"verified"},{"title":"Patient perspectives on chronic rhinosinusitis in cystic fibrosis: Symptom prioritization in the era of highly effective modulator therapy","year":2024,"journal":"International Forum of Allergy & Rhinology","source_url":"https://doi.org/10.1002/alr.23332","status":"verified"}],"source":"works"},"contact":{"address_1":"1400 JACKSON ST","city":"Denver","state":"CO","zip":"802062761","phone":"303-388-4461","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1932299518","source":"identity"},"similar":[{"name":"James Crapo","slug":"james-crapo","institution":"National Jewish Health","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/james-crapo","json_url":"https://www.findmykol.com/kol/james-crapo/profile.json"},{"name":"Barry Make","slug":"barry-make","institution":"National Jewish Health","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/barry-make","json_url":"https://www.findmykol.com/kol/barry-make/profile.json"},{"name":"Jeffrey Swigris","slug":"jeffrey-swigris","institution":"National Jewish Health","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/jeffrey-swigris","json_url":"https://www.findmykol.com/kol/jeffrey-swigris/profile.json"},{"name":"Michael Wechsler","slug":"michael-wechsler","institution":"National Jewish Health","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/michael-wechsler","json_url":"https://www.findmykol.com/kol/michael-wechsler/profile.json"},{"name":"Fernando Martinez","slug":"fernando-martinez","institution":"University of Massachusetts Chan Medical School","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/fernando-martinez","json_url":"https://www.findmykol.com/kol/fernando-martinez/profile.json"},{"name":"David Gozal","slug":"david-gozal","specialty":"Pediatric Pulmonology","url":"https://www.findmykol.com/kol/david-gozal","json_url":"https://www.findmykol.com/kol/david-gozal/profile.json"},{"name":"Ronald Crystal","slug":"ronald-crystal","institution":"Weill Cornell Medicine","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/ronald-crystal","json_url":"https://www.findmykol.com/kol/ronald-crystal/profile.json"},{"name":"Bartolome Celli","slug":"bartolome-celli","institution":"Brigham and Women's Hospital","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/bartolome-celli","json_url":"https://www.findmykol.com/kol/bartolome-celli/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":10,"funding":3,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2021-03-17","provider_certified":"2021-03-17","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}